'Fast Money' Recap: What Will a Rising Dollar Do?
at The Street - 1 hr 31 mins ago
The trading panel discussed commodities, J.C. Penney and the latest Apple rumors.
Most active New York Stock Exchange-traded stocks
AP - Wed Aug 27, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Wed Aug 27, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Early Glance: Pharmaceuticals companies
AP - Wed Aug 27, 9:18AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
3 Reasons Pfizer Inc.'s Stock Could Fall
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 27, 8:22AM CDT
Pfizer may be the largest pharmaceutical company in the world, but size isn't everything when it comes to developing and selling drugs. Over the past 16 years Pfizer's stock hasn't budged on a nominal basis. That doesn't mean Pfizer's management...
Human Vaccine Technologies Market 2014-2018 - Key Insights into the $43 Billion Industry
M2 - Wed Aug 27, 8:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hl3zqh/human_vaccine) has announced the addition of the "Human Vaccine Technologies Market" report to their offering. The global vaccine market projected to rise to $43.5 billion by 2018, growing at a CAGR of 12.65% Rapid advances in understanding of the immune system and desire of medical community to engineer both preventive and therapeutic vaccines for a wide spectrum of diseases are fueling changes in medicine and in the managed care industry. The growth of global Vaccine market is partly fuelled scientific breakthroughs such as genome sequencing of infectious pathogens, refined understanding of the immune system and its mechanism of response, followed by significant influx of money from public funding bodies, private charity and commercial organizations. Safety, demonstration of sufficiently high efficacy and lack of a consistent evaluation/development pathway are major stumbling blocks for development of new vaccines. The application of modern biological technologies and advances in genomics has resulted in novel concepts like reverse vaccinology, DNA vaccines, recombinant subunit vaccines and non-replicating vectors, some of these concepts have already progressed to advanced clinical trials and new products such as the meningococcal and hepatitis B vaccine. Recently, cancer and certain autoimmune disorders have received attention as targets for both prophylactic and therapeutic vaccines. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Vaccine Technologies Market, by End-User 5. Vaccine Technologies Market, by Type 6. Vaccine Technologies Market, by Class 7. Vaccine Technology Market, by Disease Indication 8. Regional Market Analysis 9. Company Developments 10. Major Company Profiles - Alphavax - Antigen Express, INC. - Bavarian Nordic - Genticel - Glaxo Smithkline PLC - Liquidia Technologies - Merck & CO., INC. - Novartis AG - Pfizer, INC. - Sanofi For more information visit http://www.researchandmarkets.com/research/hl...an_vaccine
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard
PR Newswire - Wed Aug 27, 8:10AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Express Scripts Holding Company (NASDAQ: ESRX) and C.R. Bard, Inc. (NYSE: BCR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5998-100free.
Will This New Rating Help Pfizer (PFE) Stock Today?
at The Street - Wed Aug 27, 8:09AM CDT
Deutsche Bank starts coverage of Pfizer (PFE) with a 'buy' rating and a $34 price target.
How the Rising Dollar May Impact Your Portfolio - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Aug 26, 8:03PM CDT
These companies could be impacted if the dollar continues to rise.
Merck, Pfizer combining drugs
at Investor's Business Daily - Tue Aug 26, 5:45PM CDT
Merck (MRK) will study its new immunotherapy drug candidate, brolizumab, in combination with Pfizer's (PFE) already-approved Xalkori to treat metastatic lung cancer. The trial is expected to start next year. In Feb. the drug giants announced they...
HCP Boasts Of 29 Years Of Dividend Increases
at Investor's Business Daily - Tue Aug 26, 4:57PM CDT
HCP (HCP) is a real estate investment trust that invests in four health-care sectors: senior housing; post-acute/skilled nursing facilities; life sciences; and medical offices and hospitals. The company manages, acquires, develops and sells...
After Yesterday's Rally of 1.04% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:42PM CDT
Pfizer (NYSE
Pfizer Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:41PM CDT
Pfizer (NYSE
Economic Data Fuel Another All-Time High For S&P 500
at Investor's Business Daily - Tue Aug 26, 2:36PM CDT
A big jump in durable goods orders and a strong reading on consumer confidence from the Conference Board fueled modest gains for the stock market Tuesday. The Dow Jones industrial average led the way, rising 0.3%. Exxon Mobil (XOM), UnitedHealth...
Why Merck (MRK) Stock Is Gaining Today
at The Street - Tue Aug 26, 2:14PM CDT
Merck (MRK) shares are climbing after the company revealed a collaborative effort with Pfizer on lung cancer treatment trials.
Ethical Pharmaceuticals Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
PRWeb - Tue Aug 26, 1:03PM CDT
Ethical pharmaceuticals or prescription drugs are those licensed drugs that are regulated by various legislation to require a written medical prescription before it can be procured. An ethical pharmaceutical product is only sold by pharmacists when it has been approved by a written medical prescription from a registered medical practitioner. The term prescription drugs or ethical pharmaceutical is usually used to distinguish the products from over-the-counter drugs--drugs that can be obtained without a written medical prescription. However, varied jurisdictions have varied definitions of what constitutes an ethical pharmaceutical. At present, ethical pharmaceuticals market is highly profitable as well as a risky market venture. The market is expected to be profitable owing to the upcoming patent expiries of many blockbuster drugs; and risky because of the involvement of many established and multinational companies who have built a global recognition for their safe and effective products.
Midday Glance: Pharmaceuticals companies
AP - Tue Aug 26, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.: